Abiopharma

Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025

Natera Announces Expansion to 20 Genes for its Fetal Focus™ Single-Gene NIPT

Overall Survival Data from HARMONi-A, Featuring Ivonescimab in Combination with Chemotherapy vs. Chemotherapy in 2L+ Treatment of Patients with EGFRm NSCLC in China, to be Showcased at SITC 2025

Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer

Sensient Technologies Corporation Reports Results for the Quarter Ended September 30, 2025

AirSculpt Technologies Announces Third Quarter Fiscal 2025 Earnings Release Date and Conference Call

LyondellBasell reports third quarter 2025 earnings

Immuron Announces Clinical Trial Update

NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth

Corbus Pharmaceuticals Announces Pricing of Public Offering